Pharma Deals
Merger and Acquisition Transactions in Pharma, Licensing Deals,
Pages
Home
Global Pharma Intelligence
Japan Pharma Intelligence
Clinical Trial Data
Health News
Investment Ideas
New Drug Approvals
Showing posts with label
Elan
.
Show all posts
Showing posts with label
Elan
.
Show all posts
Monday, 29 July 2013
Perrigo to acquire Elan for $8.6 billion
Yesterday Perrigo announced that they would be acquiring Elan for $8.6 billion. The deal brings to Perrigo an escalating Tysabri Royalty stream, tax synergies, ELNF005 (a Phase 2 CNS asset) and $1.9b in net cash.
Read more »
Older Posts
Home
Subscribe to:
Posts (Atom)